Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borrega

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Tumori|August 12, 2020
Prognostic value of the TGFβ1 rs4803455 single nucleotide polymorphism in small cell lung cancerPablo Ayala de Miguel, María Valle Enguix-Riego, Jon Cacicedo, et al.
Journal of Intensive Care|August 15, 2019
Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter studyLucie Probst, Enrico Schalk, Tobias Liebregts, et al.
European Urology Oncology|November 5, 2025
Age-related Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of the Phase 3 ARASENS TrialJoan Carles, Bertrand Tombal, Maha Hussain, et al.
Histochemistry and Cell Biology|August 28, 2021
Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1Leyre Echeazarra, Gontzal García Del Caño, Sergio Barrondo, et al.
Angewandte Chemie (International Ed. in English)|February 18, 2025
Profiling Allosteric Modulators of CB<sub>1</sub>R with an Allosteric FluoroprobeMiroslav Kosar, Themiya Perera, Rudolf L Z Ganzoni, et al.
Blood Advances|December 15, 2021
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphomaJakob J Malin, Veronica Di Cristanziano, Carola Horn, et al.
Biochemistry|August 7, 2025
Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β<sub>2</sub>-Adrenoceptor AgonistsNgan T N Phan, Leire Borrega-Roman, Bradley L Hoare, et al.
British Journal of Haematology|March 24, 2024
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapyDennis A Eichenauer, Jan-Michel Heger, Isabel Kruschel, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2004
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancerE Espinosa, S Morales, P Borrega, et al.
Critical Care (London, England)|March 14, 2026
Integrating intestinal microbiome and urinary metabolome data to predict secondary infection in critically ill patientsCharlotte Linz, Kristiyana Tsenova, Katja Dettmer, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Tumori|August 12, 2020
Prognostic value of the TGFβ1 rs4803455 single nucleotide polymorphism in small cell lung cancerPablo Ayala de Miguel, María Valle Enguix-Riego, Jon Cacicedo, et al.
Journal of Intensive Care|August 15, 2019
Prognostic accuracy of SOFA, qSOFA and SIRS criteria in hematological cancer patients: a retrospective multicenter studyLucie Probst, Enrico Schalk, Tobias Liebregts, et al.
European Urology Oncology|November 5, 2025
Age-related Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of the Phase 3 ARASENS TrialJoan Carles, Bertrand Tombal, Maha Hussain, et al.
Histochemistry and Cell Biology|August 28, 2021
Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1Leyre Echeazarra, Gontzal García Del Caño, Sergio Barrondo, et al.
Angewandte Chemie (International Ed. in English)|February 18, 2025
Profiling Allosteric Modulators of CB<sub>1</sub>R with an Allosteric FluoroprobeMiroslav Kosar, Themiya Perera, Rudolf L Z Ganzoni, et al.
Blood Advances|December 15, 2021
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphomaJakob J Malin, Veronica Di Cristanziano, Carola Horn, et al.
Biochemistry|August 7, 2025
Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β<sub>2</sub>-Adrenoceptor AgonistsNgan T N Phan, Leire Borrega-Roman, Bradley L Hoare, et al.
British Journal of Haematology|March 24, 2024
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapyDennis A Eichenauer, Jan-Michel Heger, Isabel Kruschel, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2004
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancerE Espinosa, S Morales, P Borrega, et al.
Critical Care (London, England)|March 14, 2026
Integrating intestinal microbiome and urinary metabolome data to predict secondary infection in critically ill patientsCharlotte Linz, Kristiyana Tsenova, Katja Dettmer, et al.
Pageof 16